Today, I talk about Sangamo's updated data from their talks at the WORLDSymposium. We saw updates on their MPSI and MPSII programs that the market responded to with big selling. I refer to their pre-clinical data and see how it compares to the updated human data. I finish up giving my predictions, which includes selling my 15 shares. Relevant links: https://doi.org/10.1016/j.ymthe.2018.03.002 https://investor.sangamo.com/events-and-presentations This is not investment advice www.breakingbiotech.com